ABx Group (ASX: $ABX) has announced that the latest round of independent analysis of samples from further runs of its 83%-owned subsidiary ALCORE's bath pilot batch reactor has confirmed the highest fluorine recoveries achieved to date. The rigorous experimental work and detailed process understanding have resulted in a maximum 93% fluorine recovery, providing confidence in the commercial potential of the ALCORE technology.
Achieving over 90% fluorine recovery in the latest test runs is a significant breakthrough for ALCORE, and is a result of the sustained, high level chemical engineering development conducted by the team. The results give us even more confidence that the process will perform as planned at commercial scale.
ABx Group (ASX: $ABX) has achieved a significant breakthrough in achieving the highest fluorine recovery of 93% in the latest test runs conducted by its subsidiary ALCORE. The results provide confidence in the commercial potential of the ALCORE technology, which aims to recover fluorine from 'excess bath' to produce hydrogen fluoride. The company anticipates further refining the continuous pilot plant reactor configuration design and tuning the operating conditions based on these results. This achievement marks a significant milestone in the development of ALCORE's technology and demonstrates the company's commitment to delivering materials for a cleaner future.